BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.4.2//EN TZID:America/Chicago X-WR-TIMEZONE:America/Chicago BEGIN:VEVENT UID:53@bhcgwi.org DTSTART;TZID=America/Chicago:20240514T090000 DTEND;TZID=America/Chicago:20240514T103000 DTSTAMP:20240514T190231Z URL:https://bhcgwi.org/events/bhcg-delivering-value-series-symposium-a-new -frontier-the-impact-of-anti-obesity-drugs/ SUMMARY:BHCG Delivering Value Series Symposium - A New Frontier: The Impact of Anti-Obesity Drugs DESCRIPTION:Please Join Us May 14\nA New Frontier: The Impact of Anti-Obesi ty Drugs\nHardly an hour goes by without consumers seeing an advertisement about prescription anti-obesity drugs\, which can not only improve blood sugar control but also lead to weight loss. This class of type 2 diabetes drugs\, known as glucagon-like peptide 1 or GLP-1s\, are sold under severa l different brand names by major pharmaceutical companies. Understanding a bout how these drugs work and their efficacy and cost is critical for empl oyers and health plan sponsors as they become more popular and impact bene fit plans.\n\nBHCG welcomes employers\, their advisors\, providers and oth er health care stakeholders to its latest Delivering Value Series (DVS) sy mposium. The goals of this symposium are to:\n\n Understand obesity manag ement and the role of GLP-1s as a solution in benefit plans\n Get details about the impact of benefit plan design on the utilization of anti-obesit y drugs\n Share information about which populations should have access to these drugs\n Explore the science of GLP-1s and obesity\n Provide stati stics regarding obesity’s economic impact and its impact on health and c hronic disease\n Discuss a comprehensive medical solution approach to add ress obesity\n Explore the cost of GLP-1s vs. the cost of unmanaged obesi ty\n Understand the role of Navitus\, BHCG’s pharmacy benefit managemen t partner\n Discuss the weight loss coverage landscape for employer group s\n Explore criteria options for weight loss coverage\n\nPresentations by :\n\n Srividya Kidambi\, M.D.\, MS\, Associate Professor and Chief\, Divi sion of Endocrinology and Molecular Medicine\, Froedtert &\; The Medica l College of Wisconsin\n Panel: Kevin Mead\, Obesity National Account Dir ector\, Novo Nordisk\, Inc. and Srividya Kidambi\, M.D.\, MS\, Associate P rofessor and Chief\, Division of Endocrinology and Molecular Medicine\, Fr oedtert &\; The Medical College of Wisconsin (moderated by Dave Osternd orf\, Centivo)\n Panel: Sara King\, PharmD\, Senior Manager\, Clinical Ac count Executive\, Navitus Health Solutions and Emma Holmi\, PharmD\, Clini cal Account Executive\, Navitus Health Solutions (moderated by Dave Ostern dorf\, Centivo)\n A National Practice Leader\n\nLocation:\n\nBMO\n395 N. Executive Drive\nBrookfield\, WI 53005\n\nDate &\; Time:\n\n8:30-9:00 a m (CDT): Registration\n9:00-10:30 am: Program\n\nWe strongly encourage in- person attendance\; however\, a virtual option is available. Please feel f ree to share this page with others that you think may have an interest in joining us.\n\nFor more information or if you have any questions\, please contact Jennifer LaMere at  jlamere@BHCGWI.org or 262-875-3312 x2.\n\n REGISTER TODAY!\nEducational Sponsor:\n ATTACH;FMTTYPE=image/jpeg:https://bhcgwi.org/wp-content/uploads/2024/04/dv s-event.jpg LOCATION:BMO\, 395 N. Executive Drive\, Brookfield\, WI\, 53005\, United St ates X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=395 N. Executive Drive\, Br ookfield\, WI\, 53005\, United States;X-APPLE-RADIUS=100;X-TITLE=BMO:geo:0 ,0 END:VEVENT BEGIN:VTIMEZONE TZID:America/Chicago X-LIC-LOCATION:America/Chicago BEGIN:DAYLIGHT DTSTART:20240310T030000 TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT END:DAYLIGHT END:VTIMEZONE END:VCALENDAR